2R64
Crystal structure of a 3-aminoindazole compound with CDK2
2R64 の概要
| エントリーDOI | 10.2210/pdb2r64/pdb |
| 関連するPDBエントリー | 2DUV |
| 分子名称 | Cell division protein kinase 2, N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE (3 entities in total) |
| 機能のキーワード | protein kinase, inhibitor, cell division, atp-binding, cell cycle, mitosis, nucleotide-binding, phosphorylation, polymorphism, serine/threonine-protein kinase, transferase |
| 由来する生物種 | Homo sapiens |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 34430.04 |
| 構造登録者 | Lee, J.,Choi, H.,Kim, K.H.,Jeong, S.,Park, J.W.,Baek, C.S.,Lee, S.H. (登録日: 2007-09-05, 公開日: 2008-09-09, 最終更新日: 2024-03-13) |
| 主引用文献 | Lee, J.,Choi, H.,Kim, K.H.,Jeong, S.,Park, J.W.,Baek, C.S.,Lee, S.H. Synthesis and biological evaluation of 3,5-diaminoindazoles as cyclin-dependent kinase inhibitors. Bioorg.Med.Chem.Lett., 18:2292-2295, 2008 Cited by PubMed Abstract: A novel series of 3,5-diaminoindazoles were prepared and found to be CDK inhibitors. Potent inhibitors against CDK1 and CDK2 were obtained by introduction of 1lambda(6)-isothiazolidine-1,1-dioxide at 5-position of indazole. Anti-proliferative activities of compounds were evaluated using EJ, HCT116, SW620, and A549 cancer cell lines. PubMed: 18353638DOI: 10.1016/j.bmcl.2008.03.002 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.3 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






